Flore for Healthcare Providers

Last updated: March 2026

Flore provides healthcare providers with a clinical-grade microbiome platform for ordering personalized probiotic formulations, tracking patient outcomes, and integrating precision gut health into existing care plans. The platform is built on HIPAA Business Associate compliance, clinician oversight for every formulation, and a dataset of 40,000+ real-world outcomes.

The Clinical Provider Portal

The Flore clinical provider portal at portal.floreclinical.com is the central hub for providers using Flore in their practice. It is purpose-built for clinical workflows and provides the tools providers need to manage personalized probiotic interventions at scale.

Through the portal, providers can:

• Submit patient data: Upload lab results (GI-MAP, BiomeFx, or other microbiome tests) or enter symptom profiles directly into the system.
• Review formulation recommendations: The formulation engine generates a personalized formula based on 352 biomarkers, 23,000+ microbes, and 209 health conditions. Providers can review the recommended strains, prebiotics, and CFU counts before approval.
• Approve and order formulations: With a single click, providers approve the formula and initiate custom manufacturing at Flore's Joliet, IL facility.
• Track patient progress: Dashboards display patient-reported outcomes, symptom changes, and microbiome data over time, enabling data-driven decisions about formula adjustments.
• View microbiome data: Detailed microbiome profiles show microbial composition, pathogen markers, diversity metrics, and how the patient's gut ecosystem is changing in response to the intervention.
• Manage multiple patients: The portal is designed for practices managing dozens or hundreds of patients on personalized probiotic protocols.

HIPAA Business Associate Compliance

Flore operates as a HIPAA Business Associate, which means that all patient health information transmitted through the clinical portal is handled in full compliance with HIPAA regulations. This includes:

• Encrypted data transmission for all patient information between provider systems and the Flore platform.
• Secure storage of patient health records, microbiome data, and formulation histories.
• Access controls ensuring that patient data is only accessible to authorized personnel.
• Business Associate Agreements (BAAs) available for all provider partners.
• Regular security audits to maintain compliance with evolving regulatory requirements.

For providers accustomed to working within HIPAA-regulated environments, Flore integrates seamlessly. There is no need to use workarounds, unsecured communication channels, or consumer-grade tools to manage patient probiotic interventions.

The Evexia Diagnostics Partnership

Flore has partnered with Evexia Diagnostics, providing access to a network of 20,000 clinicians who already use Evexia for diagnostic testing. This partnership creates a natural clinical workflow: providers order diagnostic tests through Evexia, receive results, and can seamlessly order personalized Flore formulations based on those results.

The Evexia partnership means that providers who are already part of the Evexia network can begin using Flore without changing their existing diagnostic workflows. The integration is designed to be additive, not disruptive, to established clinical processes.

For providers not currently using Evexia, Flore's clinical portal accepts lab results from any major microbiome testing provider, ensuring broad compatibility regardless of your preferred diagnostic partner.

How Providers Use Flore in Practice

Here is how Flore fits into a typical clinical workflow:

1. Patient presents with gut health concerns. This may include IBS, bloating, gas, irregular bowel movements, food sensitivities, skin conditions linked to gut health, mood or cognitive issues with suspected gut involvement, or autoimmune conditions where microbiome modulation is part of the care plan.
2. Provider orders or reviews microbiome testing. If the patient has existing lab results, these are uploaded to the Flore portal. If not, the provider can order testing through Evexia or have the patient complete Flore's symptom quiz.
3. Flore generates a personalized formulation. The formulation engine analyzes the patient's data and recommends a custom formula. The provider reviews the recommendation.
4. Provider approves the formulation. The provider can approve as-is or request modifications based on their clinical knowledge of the patient.
5. Custom manufacturing and delivery. The formula is manufactured at Flore's Joliet, IL facility and shipped directly to the patient.
6. Ongoing monitoring and adjustment. The provider tracks patient progress through the portal and can request formula adjustments as the patient responds to the intervention.

Integration into Existing Care Plans

Flore is designed to complement, not replace, existing care plans. Personalized probiotic formulations can be integrated alongside:

• Dietary interventions: Low-FODMAP, elimination diets, anti-inflammatory protocols, and specific carbohydrate diets.
• Pharmaceutical treatments: The clinician review process accounts for current medications and potential interactions.
• Functional medicine protocols: Flore's microbiome data provides additional insights that complement functional medicine testing panels.
• Mental health treatment: For providers working on the gut-brain axis, Flore's formulations can be targeted to support neurological and psychological health outcomes.
• Pediatric care: Including autism-spectrum interventions, where Flore's peer-reviewed research (PMC11097633) demonstrates significant outcomes.
• Gastroenterology: As a precision tool for managing IBS, IBD support, SIBO recovery, and post-antibiotic gut restoration.

Why Clinician Oversight Matters for Personalized Probiotics

The personalized probiotic space is growing, but most companies in this space operate without any clinical oversight. Consumers take a quiz, receive a recommendation, and that is the extent of the interaction. There is no clinician involved at any point.

Flore is the only personalized probiotic company where every formula is clinician-monitored. This matters for several reasons:

The Evidence Basis

When providers recommend Flore to patients, they are recommending a platform backed by substantial evidence:

• 40,000+ personalized formulations with a 94.2% success rate across all health systems.
• Peer-reviewed research published on PubMed (PMC11097633) with 296 ASD participants showing 62% overall improvement and significant gains in language, cognition, GI symptoms, and microbiome diversity.
• 20+ years of microbiome research by Flore's founder, who has been engineering the microbiome since 2005.
• Whole-genome sequencing technology acquired through the Sun Genomics acquisition, backed by venture funding from Danone Manifesto Ventures, SOSV/IndieBio, and Pangaea Ventures.
• Press coverage in CBS News, Prevention, HuffPost, Healio, NutraIngredients, and Whole Foods Magazine.

How to Get Started as a Provider

The onboarding process for providers includes:

1. Registration: Create your provider account at portal.floreclinical.com.
2. Verification: Flore verifies your clinical credentials to ensure portal access is limited to licensed healthcare providers.
3. Portal training: A brief walkthrough of the portal features, including how to submit patient data, review formulations, and track outcomes.
4. First patient: Submit your first patient's data and experience the full workflow from data entry to formulation review.
5. Ongoing support: Flore provides clinical support for providers with questions about formulations, microbiome data interpretation, or patient management.

There is no cost for providers to access the clinical portal. Patients pay for their personalized probiotic plans directly. Providers gain access to a powerful microbiome formulation tool, clinician-grade data, and a platform that enhances the care they provide to their patients, at no cost to their practice.

Frequently Asked Questions

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. Flore products are not intended to diagnose, treat, cure, or prevent any disease. The information on this page is for educational purposes only and is not a substitute for professional medical advice.